Vasopressin plays a primary role in the concentration of urine to maintain body fluid homeostasis. The collecting duct as well as thick ascending limb is a major target site of vasopressin. The antidiuretic action of vasopressin is mediated by the V2 receptor in the basolateral membrane of principal cells in the collecting ducts. The binding of vasopressin to V2 receptors causes an activation of adenylate cyclase and a synthesis of cAMP. Vasopressin regulates water and ion transport through V2 receptor-mediated ion channels and transporters. In contrast, the V1a receptor mainly in the luminal membrane of distal nephron regulates basolateral V2 receptor-mediated action with regard to water and ion transport through the activation of G and phosphoinositide turnover. Guanylate cyclase forms three q / 11 types of ANP receptors, although NPR-A and B (GC-A and B) are biologically active and related to the synthesis of cGMP. Urodilatin, synthesized by the kidney, causes natriuresis by binding to GC-A in the collecting ducts. ANP causes diuresis and natriuresis, at least in part by inhibiting the V2 receptor-mediated action of AVP in the collecting ducts. The site of interaction of ANP and AVP is post cAMP synthesis, at least in the collecting ducts. The roles of AVP and ANP under pathophysiological conditions have been reported.
Introduction
a result of volume expansion. ANP provides a negative feedback against AVP in the central nervous system (CNS) The role of the kidney is to maintain body fluid and the kidney. In the CNS, the release of AVP, principally homeostasis. Vasopressin (AVP) is a key hormone in through its vasopressor action, may stimulate the release of maintaining plasma osmolality. An increase as small as 2%
ANP [1] , with ANP in turn inhibiting the release of AVP. in plasma osmolality stimulates thirst and the secretion of In the kidney, ANP inhibits the effect of AVP on water and AVP from the postpituitary gland, followed by water ion transport [2] , thereby modulating the control of body ingestion and water reabsorption in the kidney, respectivefluid homeostasis by AVP. Since the collecting duct is a ly, after which the plasma osmolality returns to normal.
primary site of the action of AVP and ANP, we will focus The secretion of AVP is also stimulated by reductions in on the physiological effects of AVP and ANP in the the effective circulating blood volume. A decrease in the collecting duct. effective circulating blood volume increases the plasma AVP concentrations leading to a concentration of urine to 2. Localization of vasopressin and ANP receptors in prevent further loss of body fluid. The action of AVP on the kidney the kidney is affected by various factors, including atrial natriuretic peptide (ANP), endothelin, adrenomedullin, 2.1. Vasopressin receptors glucagon and oxytocin. ANP is a hormone secreted from the atrium in response to cell stretch occurring primarily as Three vasopressin receptors have been characterized macula densa [16, 17] , and the paraglomerular structure V2 receptor mRNA, detected by RT-PCR using mi-
[18] as the result of autoradiographic studies of the rat crodissected tubules from the rat, was heavily expressed in kidney. In addition, RT-PCR has revealed the expression the cortical, outer medullary and inner medullary collectof the oxytocin receptor in IMCD [19] . It has been ing duct (CCD, OMCD and IMCD, respectively) and was reported that AVP binds the oxytocin receptor with high weakly but significantly expressed in the inner medullary affinity, followed by phophoinositide hydrolysis in culthin limbs, and the medullary and cortical thick ascending tured rat IMCD cells [20] . These data suggest that the limbs (MAL and CAL, respectively) [4] . Immunohistoaction of AVP in IMCD may, at least in part, be through chemistry using a specific polyclonal antibody showed the binding to the oxytocin receptor. presence of V2 receptor protein in the basolateral membrane of the thick ascending limbs and the principal cells 2.2. ANP receptors in CCD, OMCD and IMCD [5] . Early studies measuring AVP-dependent adenylate cyclase activity carried out
The natriuretic effect of ANP was first reported by De primarily by Morel's group support these recent findings Bold et al. 20 years ago [21] . ANP binds to a membrane [6] .
form of guanylate cyclase; in other words, a membrane Radioautographic studies using V1a receptor antagonists form of guanylate cyclase is an natriuretic peptide receptor revealed the presence of V1a binding sites on the thin [22] . Guanylate cyclase has two different molecular forms: descending limbs of short loop nephrons and IMCD [7] . a soluble hem-containing enzyme and a non-hem-conV1a receptor mRNA detected by RT-PCR using microdistaining transmembrane enzyme [23] . The ANP receptor is sected renal tubules from the rat was most abundant in the membrane form of guanylate cyclase. Three types of CCD [8] . The expression was decreased in the deeper ANP receptors are known: NPR-A, B and C (GC-A, B and collecting duct and not detectable in the terminal IMCD C). NPR-A (GC-A) is a biologically active receptor that is [8] , in agreement with a previous report by Ecelbarger et activated primarily by ANP and, to a lesser extent, by al. [9] . In addition, low expression was observed in the brain natriuretic peptide (BNP) [24] [25] [26] . Another type of glomeruli and thick ascending limbs. We have recently ANP receptor, NPR-B (GC-B), cannot be stimulated by developed a specific polyclonal antibody against the V1a either ANP or BNP. C-type natriuretic peptide (CNP) receptor protein to clarify the localization of this protein in selectively stimulates NPR-B [27] . NPR-C (GC-C) has a rat kidney [8] . The labeling was seen in the glomeruli, the homologous extracellular domain with NPR-A and B, but luminal membrane and cytoplasm of MAL, CAL, CCD, has a short cytoplasmic domain without guanylate cyclase OMCD and initial IMCD. In contrast to the localization of activity. Therefore, the binding of ANP, BNP, or CNP to the V2 receptor in the principal cells, the V1a receptor was NPR-C does not stimulate cGMP production. NPR-C acts present both in the principal and intercalated cells in the as a clearance receptor that regulates circulating levels of collecting ducts. The luminal localization of the V1a ANP and has been reported to decrease synthesis of cAMP receptor may provide additional evidence for AVP action by unclear mechanisms [28, 29] . from the luminal side, which will be discussed later in this NPR-A is located throughout the entire nephron: from review.
glomeruli to IMCD [30] [31] [32] [33] [34] . We have shown that ANPV1b mRNA detected by RT-PCR is present in the induced cGMP accumulations can be observed throughout medulla in rat kidney [10] [11] [12] . In the terminal IMCD, the entire nephron segments [31] . [35] . NPR-B mRNA has also been detected in entire expression of V1b mRNA in IMCD [9] , indicating no or nephron segments [36] . Higher expression has been obvery little expression. Thus, the presence and physiological served in glomeruli and collecting ducts. In contrast, NPRrole of the V1b receptor is not clear at present. Whether C is located primarily in glomeruli, but not in tubules V1b mRNA and protein are expressed in other portions of [29, 36, 37] . the collecting ducts is not yet known.
The effects of ANP and endothelium-derived relaxing factor (EDRF) or nitric oxide (NO) are mediated by urea creates an osmotic gradient so that water moves back cGMP. Cyclic GMP modulates cGMP-gated channels, to the lumen, greatly disturbing the urine concentrating cGMP-dependent phosphodiesterase, and cGMP-dependent capacity of the kidney, indicating that a urea transporter is protein kinases (cGK). cGK exists as two major forms, also important to the water balance of the body. Indeed, cGK I and cGK II [38] . In the study by Gambaryan et al.,
UTA-1, vasopressin-regulated urea transporter, is present cGK II was localized in juxtaglomerular cells, the thin in the apical membrane and intracellular vesicles in the ascending limbs, and, to a lesser extent, the brush border of subapical portion of this segment [49] . In addition, the proximal tubules in rats [39] . Neither cGK I nor cGK II, epithelial sodium channel (ENaC) present in the collecting however, are endogenously present in the collecting ducts, duct [50, 51] also plays an important role in creating a suggesting that the effects of cGMP may be carried out by sodium gradient for water reabsorption. In Liddle other mediators. However, another report has shown the syndrome, in which ENaC is constitutively activated, presence of cGK II in freshly isolated connecting tubules hypernatremia and hypertension due to volume expansion and CCD in rabbit [40] . Although the species are different, are usually seen. AVP regulates all of these channels and the differences in the localization of cGK in these studies transporters to effectively concentrate urine in the kidney. need more investigation.
3.1. Water channels
Actions and roles of AVP in the collecting duct
In isolated tubule perfusion studies, the administration of AVP to the basolateral side was dramatically found to The main target site of AVP is the collecting duct in the increase collecting duct water permeability within a matter kidney. In the absence of AVP, the water permeability in of minutes [43, 52] (so-called short-term regulation), the collecting duct is relatively low compared to the strongly suggesting the presence of water channel in this proximal tubule and the thin descending limb of Henle's segment. With respect to this finding, AQP2 [53] , a loop, where water channel, aquaporin 1 (AQP1), is convasopressin-regulated water channel, and subsequently stitutively expressed both in the apical and basolateral AQP3 [54, 55] and AQP4 [56, 57] , both later known to be membrane [41] . In the presence of AVP, the water perconstitutively expressed in the basolateral membrane in the meability of the collecting duct can be dramatically principal cells of the collecting duct, have been identified increased (within a few minutes) [42, 43] , and is mediated [54, 55, [58] [59] [60] . This rapid response to vasopressin is by cAMP production via V2 receptors in the basolateral archived by at least two different mechanisms, i.e. the membrane of the principal cells [44] . The binding of AVP chemical modification of the water channel and a change to the V2 receptor induces the translocation of AQP2 from in the number of functional water channels in the mema store in intracellular vesicles to the apical plasma brane. Immunohistochemistry using a specific antibody membrane of the principal cells in the collecting duct [45] .
against AQP2 has shown strong labeling in the apical Because water transport is passive, the driving force, i.e. membrane and the subapical portion of the collecting duct, the osmotic gradient between the lumen and interstitium in the latter of which present in small vesicles as confirmed the renal medulla, is necessary for the movement of water by immunoelectron microscopy [61] . These observations through this channel. The medullary osmotic gradient is favor the 'membrane shuttle hypothesis' [62] , which produced primarily by the loop of Henle, which plays an proposes that water channels are stored in vesicles and important role in the countercurrent multiplication system inserted exocytically into the apical plasma membrane in together with the collecting duct. The thick ascending limb response to vasopressin. This scenario has been clearly is impermeable to water because of the absence of a water demonstrated by a combination of microperfusion and
channel and possesses a secondary active Na -K -2Cl immunohistochemistry techniques using microdissected cotransporter (NKCC2, or bumetanide-sensitive cotrans-IMCD by Nielsen et al. [45] . AVP increases the water porter 1, BSC1) in the apical membrane [46] , allowing the permeability of collecting duct cells by inducing a reversdilution of urine. In contrast, absorbed sodium accumulates ible translocation of AQP2 water channels from intracelluin the interstitium in the medulla because of the slow blood lar vesicles into the apical plasma membrane. flow and the presence of a countercurrent exchange
Because the AQP2 molecule possesses serines and between the descending and ascending vasa recta in this threonines in hydrophilic domains [53] that are potential area. These processes create an osmotic gradient between sites of phosphorylation by protein kinases, including the urine and the interstitium and allow the reabsorption of protein kinase A, it is important to clarify whether the water in the collecting duct until the osmolality of the direct phosphorylation of AQP2 by cAMP-dependent urine reaches an equilibrium with that in the interstitium.
kinase alters its transport characteristics. The changes in Urea is impermeable in the collecting duct except for the water conductancy of AQP2 by PKA-mediated phosterminal IMCD [47, 48] so that urea concentrations inphorylation (approximately 30%) [63] cannot explain the crease as urine passes through the collecting duct. If marked changes in collecting duct-water permeability in terminal IMCD is also impermeable to urea, concentrated response to vasopressin treatment (3-to 10-fold increases).
Protein kinase A (PKA)-induced phosphorylation of AQP2 Long-term regulation by AVP may not be a factor in the is more critical to the cellular localization of AQP2 [64- case of UT-A1. Northern blotting using RNA isolated from 67]. Thus, collecting duct water permeability, and hence rat inner medulla has demonstrated that the abundance of water balance, is acutely regulated by vasopressin-regthe 4.0-kb collecting duct transcript is not regulated by ulated trafficking of AQP2.
AVP [78] . In agreement with this observation, the chronic In addition to this short-term regulation, long-term administration of dDAVP to Brattleboro rats does not regulation has also been emphasized recently. This regulachange the abundance of UT-A1 protein in the inner tion takes place over a longer period (hours to days) and medulla [79] . results in changes in the total amount of AQP2 in the cells. In Barrtleboro rats, an animal model manifesting a natural knockout of circulating vasopressin, chronic administration 3.3. Epithelial sodium channel of AVP through osmotic minipumps has been observed to cause a threefold increase in AQP2 protein expression
The amiloride-sensitive epithelial sodium channel compared to controls [68] . In addition, AQP3, but not (ENaC) is a multimeric channel formed by an association AQP4, protein expression is also upregulated by chronic of a-, b-and g-subunits arranged around the pore in a exposure to AVP [69] . Upregulation of these proteins by tetrameric structure. The effect of AVP on ENaC is much AVP primarily results in an increase in the transcription different between the rat and rabbit collecting duct. rates of the AQP2 and AQP3 genes, as AQP2 contains a Sodium transporter in rat CCD is activated synergistically cAMP-responsive element in its 59-franking region [70] by mineralocorticoids and AVP [80, 81] . An electrophysioand AQP3 has an Sp1 and AP2 cis-regulatory element logical study using microperfusion of rat CCD has reassociated with cAMP-mediated transcriptional regulation vealed stable increases in sodium conductance in principal [71] . This long-term regulation may be more important cells by AVP [82] . cAMP analog, isobutylmethylxantine (a under pathophysiological conditions, as under such conphosphodiesterase inhibitor), and forskolin (a direct ditions the cells face prolonged abnormalities.
stimulator of adenylate cyclase) appear to mimic AVP action, which is blocked by amiloride, indicating that AVP 3.2. Urea transporter stimulates ENaC by cAMP production, presumably via the V2 receptor [83] . In contrast, AVP action on ENaC is more At least, four different isoforms of urea transporters complicated in the rabbit collecting duct. AVP causes (UTs) have been cloned from rat kidney so far (UT-A1, transient increases in sodium absorption followed by a UT-A2, UT-A3 and UT-A4) [72] . UT-A1 (vasopressinsustained decrease in it [84] . Using specific V1a and V2 regulated urea transporter or VRUT) is present in intracelantagonists, OPC-21268 and OPC-31260, Yoshitomi et al. lular vesicles as well as the apical plasma membrane in the [85] has tried to dissect the action of AVP through V1a and IMCD [73] as with AQP2. This localization in cells leads V2 receptors. AVP in the presence of V1a antagonist, i.e. to the possibility of dramatic increases in urea permeability pure V2 receptor-mediated action has been caused a by AVP as a result of the trafficking of UT-A1 to the apical sustained inhibition of sodium conductance, as does cAMP. membrane. However, physiological studies [74] , immunoIn contrast, AVP in the presence of V2 antagonist, i.e. pure cytochemical localization experiments, and surface V1a receptor-mediated action causes a sustained activation 21 biotinylation studies [75] do not support this view. Imof sodium conductance associated with [Ca ]i increases. munocytochemistry has revealed that AVP does not induce It thus seems likely that the effect of AVP on sodium a major redistribution of UT-A1 labeling in IMCD cells. absorption in rabbit CCD is a complex of V1a and V2 Surface biotinylation studies, although demonstrating a receptor-mediated action. Although the mechanism by marked increase in AQP2 at the surface of IMCD cells in which AVP stimulates ENaC is not yet clearly understood, response to vasopressin, have failed to show any increase it may be, at least in part, dependent on the increase in the in the surface labeling of UT-A1. All of these studies number of ENaCs in the apical membrane [86, 87] . indicate that the ability of vasopressin to activate UT-A1
In addition to short-term regulation, the long-term does not depend on stimulation of trafficking to the cell regulation of AVP by ENaC has also been suggested. surface.
Chronic exposure to AVP significantly increases the The mechanisms of the short-term regulation of UT-A1 amounts of mRNA and the translation rates of the b-and by vasopressin are not clear at present. One possibility is a g-subunits of the rat ENaC in the RCCD1 rat CCD cell cAMP-mediated phosphorylation of UT-A1. It has been line [88] . It has recently been confirmed by an in vivo reported that UT-A1 is phosphorylated in response to AVP study, in which quantitative immunoblotting was carried stimulation in suspension of rat IMCD [76] and that out with the polyclonal antibody against three subunits of serine-499, found in the middle loop of the UT-A1 protein, ENaC, that there is an increase in the whole kidney is important to the activation of UT-A1 by cAMP [77] .
abundance of b-and g-subunits in Brattleboro rats infused Further study to estimate a functional role for such with dDAVP for 7 days and in 7-day water restricted phosphorylation in the regulation of UT-A1 is necessary.
Sprague-Dawley rats [87] . 3.4. Na -K -2Cl cotransporter 1 (NKCC1) the extracellular space, and nearly all of this hormone in plasma is in an unbound form, which, because of its
Two types of bumetanide-sensitive Na -K -2Cl corelatively low molecular weight, permeates peripheral and transporters have been characterized. The absorptive type, glomerular capillaries readily so that the urinary excretion NKCC2 (BSC1), is located in the luminal membrane in rate of AVP is extraordinary high. According to currently MAL and CAL [89] [90] [91] and is the main engine for available data, the urinary clearance of AVP in human is 21 21 countercurrent multiplication system. In contrast, the sec-0.1-0.6 ml kg min and may reach 2.0 21 21 retory type, NKCC1 (BSC2) mRNA and protein, is ml kg min [109] . Thus, urinary concentrations of expressed in the collecting duct in rat kidney [92] . The AVP range from 5 to 500 pM and may reach as high as physiological role of NKCC1 in the collecting duct is not 1700 pM. It has been reported that in the rabbit CCD, clear. The physiological role of NKCC1 may be related to luminal AVP suppresses the increase in water permeability the acid-base balance. Net acid excretion is the sum of (Lp) induced by basolateral AVP [110] . Furthermore, a ammonium and titratable acid excretion if there is no microperfusion study using isolated rat terminal IMCD has 1 1 bicarbonate wasting. NH has been shown to replace K clearly demonstrated that luminal AVP inhibits osmotic 4 in NKCC1 [93] . The expression of NKCC1 (BSC2) water and urea permeability by 30-65% in the presence of mRNA and protein in OMCD are highest among the bath AVP by decreasing cAMP accumulations via V1a or collecting duct [94] , which is consistent with the high oxytocin receptors and by an unknown mechanism via V2 capacity for acid excretion in OMCD [95] . Ammonia is receptors in the luminal membrane [5] . An electrophysioprimarily produced in the proximal tubules by phosphatelogical study using microperfusion of rabbit CCD has dependent glutaminase and accumulates in the medullary revealed that luminal AVP inhibits the stimulation of luminal pH, has been thought to be the primary route of chronic renal failure [112] . ammonium excretion, at least under control conditions [95] . It has been reported that the participation of NKCC1 in ammonium excretion in OMCD is only 6% under 5. Physiological role of ANP in the collecting ducts control conditions [99] . However, chronic metabolic acidosis upregulates NKCC1 mRNA and protein in OMCD The physiological effects of ANP involve an increase in of the rat, suggesting a contribution of NKCC1 to the the glomerular filtration rate (GFR), changes in hemoacid-base balance under this chronic condition [94] . It is dynamics, and an inhibition of the tubular reabsorption of interesting that dehydration stimulates both NKCC1 NaCl [113, 114] . Recent reports have shown that NPR-A mRNA and protein expression in OMCD [94] . The chronic (GC-A)-deficient mouse cannot show natriuresis in reexposure to AVP in the rat also increased NKCC1 mRNA sponse to an isooncotic saline infusion, suggesting that and protein expression [100] , suggesting some role of AVP NPR-A is essential for natriuresis [115] . However, NPR-A in the regulation of NKCC1 expression in OMCD.
is not required for normal kidney function under nonisooncotic conditions. Micropuncture studies have suggested that the main site of ANP action is IMCD [116- 
Modification of AVP action by AVP itself
122]. Regarding the direct tubular effects of ANP, Harris et al. were the first to report that ANP inhibits angiotensin-4.1. Basolateral side induced sodium and fluid absorption in proximal tubules perfused in vitro with the standing-droplet method [123] . The action of cAMP produced by AVP through the V2 However, most subsequent studies have not observed any receptor is modified by phosphoinositide pathway activated inhibitory effects of ANP on angiotensin II-stimulated fluid by AVP itself. Much data has shown that intracellular absorption [124] [125] [126] [127] . In the loop of Henle, we have found calcium [13, [101] [102] [103] [104] and protein kinase C [105] are also that ANP inhibits AVP-stimulated chloride transport in increased by AVP, resulting in an inhibition of water long-looped MAL [128] . Some studies have not found any permeability. Receptors responsible for this modification inhibitory effects of ANP in the thick ascending limbs are presumably the V2 receptor in rat IMCD [9,13,101- [129, 130] . We have also observed effects of ANP on 2 
103
] and V1a receptor in rabbit CCD [106] and rat CCD HCO transport in MAL [131] .
3 [107, 108] . In contrast to the small physiological effects of ANP in the proximal tubules and thick ascending limbs, large 4.2. Luminal side effects have been reported in the collecting ducts. In CCD, we have demonstrated inhibitory effects of ANP and AVP is distributed in a volume approximately equal to cGMP on active chloride transport both in the presence and absence of AVP [132] . Low concentrations of ANP significant reduction in AQP2 protein and mRNA levels
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(10 M) inhibit fluid absorption by 50%, suggesting the [144] . physiological significance of ANP in this segment. These effects have been observed without changing the trans-6.2. Liver cirrhosis epithelial voltage, suggesting that ANP inhibits thiazidesensitive sodium chloride transport in rat CCD.
Hepatic cirrhosis is another chronic condition associated Many studies have shown that ANP inhibits NaCl with pathologic water retention and increased plasma transport in IMCD. ANP inhibits oxygen consumption and levels of vasopressin. The changes in AQP2 expression 22 Na fluxes in IMCD cell suspensions, single channel differ significantly depending on the model of hepatic currents in cultured IMCD cells as shown by patch-clamp cirrhosis that is studied. Hepatic cirrhosis induced by technique, and NaCl absorption as shown by isolated chronic intraperitoneal administration of carbon tetratubule perfusion technique [133] [134] [135] [136] [137] [138] . The first report of chloride is associated with an increased expression of both the effect of ANP on water permeability was presented by AQP2 protein and AQP2 mRNA [145, 146] . Cirrhosis Dillingham and Anderson based on their observations of induced by ligation of the common bile duct [147, 148] has rabbit CCD [2] . We have demonstrated that ANP inhibits demonstrated a significant reduction in AQP2 expression. AVP-stimulated water permeability by 40-50% using Hepatic cirrhosis by carbon tetrachloride inhalation is isolated tubule perfusion [139] , an effect that is mimicked associated with ascites and hyponatremia due to excessive by cGMP, and other investigators have confirmed these water retention. However, no change in AQP2 expression findings [140] . Although we have demonstrated the inhibhas been observed in this model of cirrhosis, whereas itory effects of ANP on AVP-stimulated osmotic water AQP1 expression in the cortex is increased [149] , sugpermeability in IMCD, the effect was not observed in the gesting that the water retention is, in part, due to increased 29 presence of high doses of AVP (10 M). An effect of reabsorption in the proximal tubule, combined with a ANP on water permeability has been observed only in the failure of the normal 'vasopressin escape' phenomenon.
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presence of low doses of AVP (10 M). In contrast, ANP Additional studies are needed to fully clarify the role of does not inhibit AVP-stimulated urea permeability in aquaporins and solute transporters in compensated and IMCD [139] . decompensated cirrhosis. Urodilatin is identical to ANP except for a four-aminoacid NH -terminal extension. Urodilatin cannot be detected 6.3. Chronic renal failure 2 in plasma [141] . Urodilatin is synthesized by the kidney most likely in the connecting tubule and is secreted into Impairment of vasopressin-stimulated water reabsorption the tubular lumen of collecting ducts, where it binds to in the kidney collecting duct [150, 151] is known in rats GC-A and affects water and sodium transport [142, 143] .
with chronic renal failure. Chronic renal failure induced by These data suggest that urodilatin may be the predominant 5 / 6 nephrectomy is associated with polyuria and a vasrepresentative of natriuretic peptides in human kidney.
opressin-resistant downregulation of AQP2 and AQP3 [152] , suggesting that reduced AQP2 and AQP3 levels may be significant factors involved in the impaired collecting duct water permeability and reduced or impaired 6. Role of AVP under pathophysiological conditions vasopressin responsiveness in chronic renal failure. We have shown that urinary AVP is an intrinsic diuretic, The plasma AVP and ANP concentrations are altered especially in patients with chronic renal failure, based under various chronic pathophysiological conditions, inupon evidence that luminal AVP inhibits basolateral AVPcluding congestive heart failure, liver cirrhosis and nepstimulated water permeability [5, 112] . hritic syndrome. Recently, many investigators have pointed out that the chronic increase or decrease in AVP may play an important role in the abnormality of the body-fluid 7. Actions and roles of ANP in the collecting duct balance in some of these conditions. 7.1. Short-term regulation 6.1. Congestive heart failure As a mechanism of ANP action, cGMP acts as a second Congestive heart failure is associated with salt and water messenger. The stimulation of cGMP synthesis by ANP retention. Increased AQP2 expression and enhanced delivinhibits AVP (V2) action in IMCD. Since the second ery to the apical plasma membrane play a significant role messenger of AVP is cAMP, the reduction in cAMP in water retention and the development of hyponatremia is synthesis by ANP was considered. In fact, ANP reduces associated with severe heart failure. Rats with congestive the cAMP content by enhancing phosphodiesterase activity heart failure have significantly increased plasma vasopresin human fibroblasts [153] . However, AVP-stimulated sin levels, and the administration of the vasopressin-V2 cAMP accumulations in IMCD nor MAL are not changed receptor antagonist OPC 31260 is associated with a by ANP, suggesting that the site of ANP action on AVP is distal to cAMP synthesis. It is not known whether the luminal membrane of distal nephron, regulates basolateral stimulation of cGK is a major effector of ANP action in V2 receptor-mediated action on water and ion transport the collecting ducts. Hyperosmolality reduces ANP-stimuthrough the activation of G and phosphoinositide q / 11 lated cGMP generation in IMCD, suggesting that the turnover. ANP causes diuresis and natriuresis, at least in increase in medullary osmolality, such as in dehydration, part, by inhibiting the V2 receptor-mediated action of AVP reduces the natriuretic effects of ANP [154] .
in the collecting ducts. [157] and diabetes mellitus [158] . It is interesting that and V2 vasopressin receptors (V1a-R, V2-R) by acute and chronic sodium status affects NPR-B mRNA expression, but not metabolic acidosis in rat. J Am Soc Nephrol 1999;1025a (abstract). been reported [160] . Upregulation of GC-A in renal papilla in DOCA-salt-treated rats [161] . 
